AbbVie Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
AbbVie Inc.
CIK #0001551152
EDGAR Form CIK 2011 - 2025
10-K [0001551152]
10-Q [0001551152]
3 [0001551152]
4 [0001551152]
8-K [0001551152]
D [0001551152]
SC 13D [0001551152]
SC 13G [0001551152]
Form 13D/13G Filer Form 13D/13G Subject Filed
AbbVie Inc Xilio Therapeutics Inc [2025-02-18]
AbbVie Inc Exicure Inc [2017-10-06]
Capital Research Global Investors AbbVie Inc [2016-11-10]
AbbVie Inc Reata Pharmaceuticals Inc [2016-06-06]
Capital Research Global Investors AbbVie Inc [2014-02-13]
Vanguard Group Inc AbbVie Inc [2014-02-10]
AbbVie Inc Enanta Pharmaceuticals Inc [2014-02-07]
BlackRock Inc AbbVie Inc [2014-01-28]
Form 3/4/5 Subject 2011 - 2025
AbbVie Inc.
Saleki-Gerhardt Azita
Donoghoe Nicholas
Quaggin Susan E
Alpern Robert J
Rapp Edward J
Falk Thomas J
Meyer Melody B
Hart Brett J
Davis Jennifer L.
Burnside William HL
Austin Roxanne S
Tilton Glenn F
Freyman Thomas C
Waddell Frederick H
Roberts Rebecca B
Gonzalez Richard A
Stewart Jeffrey Ryan
Reents Scott T
Purdue David Ryan
Siatis Perry C
Richmond Timothy J
Michael Robert A.
Buckbee Kevin K
Thakkar Roopal
Hudson Thomas J
Strom Carrie C
Sorg Elaine K.
Durkin Brian L
Severino Michael
Gosebruch Henry O
Liddy Edward M
Schumacher Laura J
Alban Carlos
Chase William J
Reata Pharmaceuticals Inc
Hurwich Thomas A
Roberts Roy S
Leonard John M
Abbott Laboratories
Linder Greg W
Terms | Privacy | Guide
tony@aum13f.com